ResMed

Tweet this page
<
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 26 Jan 2021
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

75,000€

Financial year: Jul 2019 - Jun 2020

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

2

Lobbying Costs over the years

  • Info

    ResMed   (RMD)

    EU Transparency Register

    209143033529-94 First registered on 21 Dec 2018

    Goals / Remit

    ResMed (NYSE: RMD, ASX: RMD) manufactures cloud-connected durable medical equipment used to diagnose and treat sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Through our devices, patients are remotely monitored at home with connected care and many use myAir™, a patient engagement mobile application. Its 7,500-member team strives to improve patients’ quality of life, promote therapy adherence, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.

    Main EU files targeted

    - Implementation of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices (MDR)
    - Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (GDPR)
    - Cybersecurity Package: Proposal for a Regulation on ENISA, the "EU Cybersecurity Agency", and on Information and Communication Technology cybersecurity certification (''Cybersecurity Act'')
    - Commission Communication on enabling the digital transformation of health and care in the Digital Single Market; empowering citizens and building a healthier society
    - Horizon Europe framework programmes
    - European Strategy for Data (COM(2020) 66 final)
    - White Paper on Artificial Intelligence (COM(2020) 65 final)
    - Consultation on “Legislative framework for the governance of common European data spaces”
    - Inception impact assessment document Ares(2020)3896535 for the Proposal for a legal act laying down requirements for Artificial Intelligence

    Address

    Head Office
    9001 Spectrum Center Blvd
    San Diego 92123
    UNITED STATES
    EU Office
    Grote Steenweg 50
    Kontich-Waarloos 2550
    BELGIUM
  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 26 Jan 2021

    Name Start date End Date
    Ms Justyna VANDENBOSCH 25 Jan 2024 24 Jan 2025
    Ms Francesca RISSO 24 Jan 2024 23 Jan 2025
    Ms Justyna VANDENBOSCH 25 Jan 2023 25 Jan 2024
    Ms Francesca RISSO 22 Oct 2022 21 Oct 2023

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    MedTech Europe: https://www.medtecheurope.org/
    Personal Connected Health Alliance: https://www.pchalliance.org/
    Digital Policy Round Table (DPRT)

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jul 2019 - Jun 2020

    Lobbying costs for closed financial year

    75,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    - Engaging with European Commission officials including Commissioners, cabinet members and services in DGs such as DG Connect, DG Grow, DG Sante, and DG Research; with MEPS and secretariats on committees such as IMCO, ENVI and ITRE; and with officials in the Working Party on Pharmaceuticals and Medical Devices in the Council of Ministers and Permanent Representations
    - Attending public hearings and events hosted in the EU institutions related to healthcare and digital policy

    Other activities

    None declared

  • Meetings

    Meetings

    2 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard